Epclusa Prices, Coupons and Patient Assistance Programs
Epclusa (sofosbuvir/velpatasvir) is a member of the antiviral combinations drug class and is commonly used for Hepatitis C.
Epclusa Prices
The cost for Epclusa oral pellet (150 mg-37.5 mg) is around $26,250 for a supply of 28 pellet, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
A generic version of Epclusa is available, see sofosbuvir/velpatasvir prices.
This Epclusa price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Oral Pellet
Quantity | Per unit | Price |
---|---|---|
28 | $937.51 | $26,250.26 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Quantity | Per unit | Price |
---|---|---|
28 | $937.51 | $26,250.26 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Oral Tablet
Quantity | Per unit | Price |
---|---|---|
28 | $937.51 | $26,250.26 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Quantity | Per unit | Price |
---|---|---|
28 | $937.51 | $26,250.26 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Epclusa Coupons and Rebates
Epclusa offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Epclusa Co-Pay Coupon Program: Eligible patients may pay no more than $5 per prescription; offer is valid for 6 months after first use; for additional information contact then program at 844-437-2587.
- Applies to:
- Epclusa
- Number of uses:
- 6 months after 1st use
Form more information phone: 844-437-2587 or Visit website
Asegua Co-pay Coupon Program for Generic of Epclusa (Sofosbuvir/Velpatasvir): Eligible patients may pay as little as $5 per prescription fill; offer valid for 6 months from the time of first use; for additional information contact the program at 800-445-3235.
- Applies to:
- Epclusa
- Number of uses:
- 6 months from the time of first use
Form more information phone: 800-445-3235 or Visit website
Patient Assistance Programs for Epclusa
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Support Path Patient Assistance Program
Elligibility requirements:- Must be uninsured or underinsured
- At or below 500% of FPL
- Medically Necessary as determined by a Doctor
- The patient must also be permanently residing in the US or US territories.
- *500% FPL or less than $100k for the household Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
- Epclusa (sofosbuvir-velpatasvir) Pellets; Oral
- Epclusa (sofosbuvir-velpatasvir) Tablet
More information please phone: 855-769-7284 Visit Website
Provider: HealthWell Foundation Copay Program
Elligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Epclusa (sofosbuvir-velpatasvir) Tablet
More information please phone: 800-675-8416 Visit Website
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Epclusa (sofosbuvir-velpatasvir) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: Good Days Program
Elligibility requirements:- Must have insurance
- At or below 500% of FPL
- FDA-approved diagnosis
- The patient must also be a US resident with a Social Security Number.
- Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
- Epclusa (sofosbuvir-velpatasvir) Tablet
More information please phone: 877-968-7233 Visit Website
More about Epclusa (sofosbuvir / velpatasvir)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (314)
- Patient tips
- Drug images
- Compare alternatives
- En español
- Drug class: antiviral combinations
- FDA approval history